Alejandra Camacho-Soto1, Anat Gross1, Susan Searles Nielsen1, Anna N Miller1, Mark N Warden1, Amber Salter1, Brad A Racette2. 1. From the Departments of Neurology (A.C.-S., A.G., S.S.N., M.N.W., B.A.R.) and Orthopedic Surgery (A.N.M.) and Division of Biostatistics (A.S.), Washington University School of Medicine, St. Louis, MO; and School of Public Health, Faculty of Health Sciences (B.A.R.), University of the Witwatersrand, Johannesburg, South Africa. 2. From the Departments of Neurology (A.C.-S., A.G., S.S.N., M.N.W., B.A.R.) and Orthopedic Surgery (A.N.M.) and Division of Biostatistics (A.S.), Washington University School of Medicine, St. Louis, MO; and School of Public Health, Faculty of Health Sciences (B.A.R.), University of the Witwatersrand, Johannesburg, South Africa. racetteb@neuro.wustl.edu.
Abstract
OBJECTIVE: To examine the association between fractures and Parkinson disease (PD) during the 5-year prodromal phase as compared to controls. METHODS: We performed a population-based case-control study of Medicare beneficiaries in the United States from 2004 to 2009. We identified 89,632 incident PD cases and 117,760 comparable controls 66-90 years of age in 2009. PD case status was the outcome, and noncranial fracture the independent variable. We used logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for association between fracture and PD in yearly time intervals prior to PD diagnosis/control reference date, after adjusting for covariates. RESULTS: There were 39,606 total fractures (25.4% cases, 14.3% controls) over the 5 years prior to the PD diagnosis/control reference date. PD was positively associated with fractures even after adjusting for age, sex, race/ethnicity, Charlson comorbidity index, alcohol use, tobacco use, and osteoporosis. The association between PD and fracture was evident at yearly time windows prior to PD diagnosis/control reference date. The association between PD and each type of fracture strengthened as the PD diagnosis/control reference date approached (all time interaction p values ≤0.02). Among beneficiaries with a mechanism of injury, the majority were attributed to falls (74.6% cases, 72.8% controls). CONCLUSION: Fractures occur more commonly during the prodromal period of PD compared to controls, especially as diagnosis date approached, suggesting that patients with PD may experience unrecognized motor and nonmotor symptoms.
OBJECTIVE: To examine the association between fractures and Parkinson disease (PD) during the 5-year prodromal phase as compared to controls. METHODS: We performed a population-based case-control study of Medicare beneficiaries in the United States from 2004 to 2009. We identified 89,632 incident PD cases and 117,760 comparable controls 66-90 years of age in 2009. PD case status was the outcome, and noncranial fracture the independent variable. We used logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for association between fracture and PD in yearly time intervals prior to PD diagnosis/control reference date, after adjusting for covariates. RESULTS: There were 39,606 total fractures (25.4% cases, 14.3% controls) over the 5 years prior to the PD diagnosis/control reference date. PD was positively associated with fractures even after adjusting for age, sex, race/ethnicity, Charlson comorbidity index, alcohol use, tobacco use, and osteoporosis. The association between PD and fracture was evident at yearly time windows prior to PD diagnosis/control reference date. The association between PD and each type of fracture strengthened as the PD diagnosis/control reference date approached (all time interaction p values ≤0.02). Among beneficiaries with a mechanism of injury, the majority were attributed to falls (74.6% cases, 72.8% controls). CONCLUSION: Fractures occur more commonly during the prodromal period of PD compared to controls, especially as diagnosis date approached, suggesting that patients with PD may experience unrecognized motor and nonmotor symptoms.
Authors: Aron S Buchman; Joshua M Shulman; Sukriti Nag; Sue E Leurgans; Steven E Arnold; Martha C Morris; Julie A Schneider; David A Bennett Journal: Ann Neurol Date: 2012-02 Impact factor: 10.422
Authors: V Barell; L Aharonson-Daniel; L A Fingerhut; E J Mackenzie; A Ziv; V Boyko; A Abargel; M Avitzour; R Heruti Journal: Inj Prev Date: 2002-06 Impact factor: 2.399
Authors: Joan D Penrod; Ann Litke; William G Hawkes; Jay Magaziner; John T Doucette; Kenneth J Koval; Stacey B Silberzweig; Kenneth A Egol; Albert L Siu Journal: J Gerontol A Biol Sci Med Sci Date: 2008-08 Impact factor: 6.053
Authors: Alejandra Camacho-Soto; Mark N Warden; Susan Searles Nielsen; Amber Salter; David L Brody; Heidi Prather; Brad A Racette Journal: Ann Neurol Date: 2017-10-31 Impact factor: 10.422
Authors: Irena S Cenzer; Victoria Tang; W John Boscardin; Alexander K Smith; Christine Ritchie; Margaret I Wallhagen; Roxanne Espaldon; Kenneth E Covinsky Journal: J Am Geriatr Soc Date: 2016-06-13 Impact factor: 5.562
Authors: Tae-Lim Kim; Seong Jun Byun; Min Yong Seong; Byung-Mo Oh; Sang Jun Park; Han Gil Seo Journal: J Bone Miner Metab Date: 2022-03-26 Impact factor: 2.626
Authors: Mark N Warden; Susan Searles Nielsen; Alejandra Camacho-Soto; Roman Garnett; Brad A Racette Journal: PLoS One Date: 2021-08-26 Impact factor: 3.240